CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 131 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $308,666 | +100.1% | 13,068 | +26.3% | 0.00% | – |
| Q3 2023 | $154,244 | +21.7% | 10,345 | -10.7% | 0.00% | – |
| Q2 2023 | $126,790 | +153.6% | 11,579 | -15.4% | 0.00% | – |
| Q3 2021 | $50,000 | -27.5% | 13,684 | -14.0% | 0.00% | – |
| Q2 2021 | $69,000 | 0.0% | 15,903 | +3.9% | 0.00% | – |
| Q1 2021 | $69,000 | -15.9% | 15,301 | +7.6% | 0.00% | – |
| Q4 2020 | $82,000 | +164.5% | 14,224 | -31.2% | 0.00% | – |
| Q1 2020 | $31,000 | +55.0% | 20,686 | +106.3% | 0.00% | – |
| Q4 2019 | $20,000 | -94.2% | 10,028 | -67.9% | 0.00% | – |
| Q3 2018 | $347,000 | -15.8% | 31,276 | +1.9% | 0.00% | – |
| Q2 2018 | $412,000 | – | 30,703 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $11,887,000 | 8.85% |
| Foresite Capital Management IV, LLC | 1,787,094 | $12,939,000 | 2.92% |
| Copernicus Capital Management, LLC | 278,416 | $2,016,000 | 1.92% |
| Sio Capital Management, LLC | 1,159,236 | $8,393,000 | 1.66% |
| ACUTA CAPITAL PARTNERS, LLC | 765,000 | $5,539,000 | 1.50% |
| Avoro Capital Advisors LLC | 10,300,000 | $74,572,000 | 1.06% |
| Boxer Capital, LLC | 4,000,000 | $28,960,000 | 1.00% |
| Vivo Capital, LLC | 2,089,356 | $15,127,000 | 0.87% |
| EAM Global Investors LLC | 284,534 | $2,060,000 | 0.76% |
| Versant Venture Management, LLC | 543,753 | $3,937,000 | 0.72% |